MIR-206

There are 2 papers on MIR-206 in aging research: none in people yet, 1 in animals, 1 review.

Gene

2 papers study it3 findings

HGNCNCBI GeneTaxon

See all 2 papers on MIR-206

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Animals1

Effects

2

Amyotrophic lateral sclerosis

downin reviews1

1 study
  1. MIR-206 protects against amyotrophic lateral sclerosis in ALS.

    “showing miR-206 as harmful in Alzheimer's, stroke, and depression, but potentially protective in amyotrophic lateral sclerosis (ALS).”

    Reviewin ALS

    miRNA-206 in muscle and central nervous system crosstalk during exercise: A double-edged sword with therapeutic potential

    Neuroscience and biobehavioral reviews

More on Amyotrophic lateral sclerosis

BDNF

downin reviews1

1 study
  1. MIR-206 inhibits BDNF in CNS.

    “where it targets brain-derived neurotrophic factor (BDNF), reducing neuroplasticity”

    Reviewin CNS

    miRNA-206 in muscle and central nervous system crosstalk during exercise: A double-edged sword with therapeutic potential

    Neuroscience and biobehavioral reviews

More on BDNF

Associations

1

PPARγ

upin rats1

1 study
  1. MIR-206 is associated with PPARγ in the moderate-intensity resistance training group (r = 0.908, p = 0.012).

    “myomiR-206 and peroxisome proliferator-activated receptor gamma (PPARγ) (r = 0.908; p = 0.012) in the MIRT group”

    Animalsin the moderate-intensity resistance training groupmales

    MyomiR-OsteomiR crosstalk induced by different modes and intensities of exercise training and its role in controlling osteogenic differentiation in old male Wistar rats

    Experimental gerontology

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months